After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Syros Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Syros Pharmaceuticals Inc is $4.96M. A total of 1.19 million shares were traded on the day, compared to an average of 9.13M shares.
In the most recent transaction, Flagship Pioneering Fund VII, bought 1,135,308 shares of SYRS for 0.24 per share on Dec 27 ’24. In a previous transaction on Dec 30 ’24, AKKARAJU SRINIVAS bought 9,333 shares at 0.25 per share.
Among the insiders who bought shares, Flagship Pioneering Fund VII, acquired of 1,331,624 shares on Dec 27 ’24 at a per-share price of $0.21. In another insider transaction, Flagship VentureLabs IV LLC bought 21,333 shares at $0.23 per share on Dec 13 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SYRS has a high of $7.96 and a low of $0.16.
As of this writing, SYRS has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.7 per share and a lower estimate of -$0.81.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SYRS’s latest balance sheet shows that the firm has $130.37M in Cash & Short Term Investments as of fiscal 2021. There were $65.19M in debt and $31.51M in liabilities at the time. Its Book Value Per Share was -$0.41, while its Total Shareholder’s Equity was $85.22M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SYRS is Buy with a score of 3.00.
